Your session is about to expire
← Back to Search
GIK Therapy for Broken Leg Bones (MAGIK Trial)
MAGIK Trial Summary
This trial will test a glucose-insulin-potassium therapy to reduce muscle damage, rhabdomyolysis and kidney injury in patients with leg fractures. 40 patients will be randomized to use the therapy or a control.
MAGIK Trial Timeline
Treatment Details
Study Objectives
Outcome measures can provide a clearer picture of what you can expect from a treatment.Side effects data
From 2014 Phase 4 trial • 40 Patients • NCT01602692MAGIK Trial Design
Find a Location
Who is running the clinical trial?
Media Library
- I survived less than 72 hours after my femur surgery.I have had a fracture due to my disease.I have a broken thigh bone or shin bone.I am under 18 years old.I have a fracture related to low energy and bisphosphonate use.I have had weakness in my arms or legs due to a stroke or other neurological condition.I am allergic or cannot take certain medications required for the study.
- Group 1: GIK Therapy
- Group 2: Placebo Control
- Screening: It may take up to 3 Weeks to process to see if you qualify in this trial.
- Treatment: The duration you will receive the treatment varies.
- Follow Ups: You may be asked to continue sharing information regarding the trial for 6 Months after you stop receiving the treatment.
Frequently Asked Questions
Are there any available slots in this clinical trial?
"According to information hosted on clinicaltrials.gov, this particular medical trial is no longer actively seeking participants; it was initially posted on January 1st 2023 and its most recent update occurred November 17th 2022. Despite the fact that there are not any current openings for this study, 347 other trials have open slots right now."
Has GIK Therapy been given a stamp of approval by the Food and Drug Administration?
"While the efficacy of GIK Therapy is yet to be determined, there is some clinical data demonstrating its safety, scoring it a 2 on our internal rating system."
Share this study with friends
Copy Link
Messenger